Next Article in Journal
Preliminary RNA-Seq Analysis of Long Non-Coding RNAs Expressed in Human Term Placenta
Next Article in Special Issue
The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
Previous Article in Journal
An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population
Previous Article in Special Issue
PPARs and Energy Metabolism Adaptation during Neurogenesis and Neuronal Maturation
Open AccessReview

Insights into the Role of PPARβ/δ in NAFLD

by Jiapeng Chen 1,2, Alexandra Montagner 3,4, Nguan Soon Tan 1,2,5,6 and Walter Wahli 1,3,7,*
1
Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232, Singapore
2
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore
3
ToxAlim, Research Center in Food Toxicology, National Institute for Agricultural Research (INRA), 180 Chemin de Tournefeuille, 31300 Toulouse, France
4
Institut National de La Santé et de La Recherche Médicale (INSERM), UMR1048, Institute of Metabolic and Cardiovascular Diseases, 31027 Toulouse, France
5
KK Research Centre, KK Women’s and Children Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore
6
Institute of Molecular and Cell Biology, Agency for Science Technology & Research, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore
7
Center for Integrative Genomics, University of Lausanne, Génopode, CH-1015 Lausanne, Switzerland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 1893; https://doi.org/10.3390/ijms19071893
Received: 15 May 2018 / Revised: 13 June 2018 / Accepted: 23 June 2018 / Published: 27 June 2018
(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries. Although usually associated with obesity, NAFLD is also diagnosed in individuals with low body mass index (BMI) values, especially in Asia. NAFLD can progress from steatosis to non-alcoholic steatohepatitis (NASH), which is characterized by liver damage and inflammation, leading to cirrhosis and hepatocellular carcinoma (HCC). NAFLD development can be induced by lipid metabolism alterations; imbalances of pro- and anti-inflammatory molecules; and changes in various other factors, such as gut nutrient-derived signals and adipokines. Obesity-related metabolic disorders may be improved by activation of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)β/δ, which is involved in metabolic processes and other functions. This review is focused on research findings related to PPARβ/δ-mediated regulation of hepatic lipid and glucose metabolism and NAFLD development. It also discusses the potential use of pharmacological PPARβ/δ activation for NAFLD treatment. View Full-Text
Keywords: PPARβ/δ; NAFLD; NASH; steatosis; liver; lipid metabolism PPARβ/δ; NAFLD; NASH; steatosis; liver; lipid metabolism
Show Figures

Figure 1

MDPI and ACS Style

Chen, J.; Montagner, A.; Tan, N.S.; Wahli, W. Insights into the Role of PPARβ/δ in NAFLD. Int. J. Mol. Sci. 2018, 19, 1893.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop